Micropoint Bioscience, Inc. is a global provider of rapid, accurate, point-of-care testing (POCT) systems and solutions.
Reducing the time required to diagnose a cardiac event can be a key factor in saving the lives of patients with acute heart conditions. Micropoint's point-of-care and nearside products enable medical and caregiving teams to test for a range of cardiac disease markers, efficiently manage patient hospital stay, and provide support for an improved quality of life back at home. The company's innovative mLabs® and qLabs® platforms, based on groundbreaking MEMS and microfluidics technology, offer both bedside and wireless handheld testing for accurate results within minutes.
Founded in 2006, Micropoint Bioscience, Inc. is headquartered in Santa Clara, California. The companys Chinese operations are located in Shenzhen. Micropoints manufacturing facilities in the U.S. and China are both GMP-and ISO13485 certified.